论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
结合全身炎症标志物和传统预后因素的新型列线图预测中国西南地区慢性心力衰竭患者的不良事件
Authors Liu Z , Zhang R, Xv Y, Wang J, Chen J, Zhou X
Received 24 March 2022
Accepted for publication 18 October 2022
Published 20 December 2022 Volume 2022:15 Pages 6785—6800
DOI https://doi.org/10.2147/JIR.S366903
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Ning Quan
Objective: Inflammation contributes to the pathogenesis and progression of heart failure (HF). This study aimed to construct a nomogram based on systemic inflammatory markers and traditional prognostic factors to assess the risk of adverse outcomes (cardiovascular readmission and all-cause death) in patients with chronic heart failure (CHF).
Methods: Data were retrospectively collected from patients with HF admitted to the Department of Cardiovascular Medicine at the First Affiliated Hospital of Chongqing Medical University from January 2018 to April 2020, and each patient had complete follow-up information. The follow-up duration was from June 2018 to May 31, 2022. 550 patients were included and randomly assigned to the derivation and validation cohorts with a ratio of 7:3, and prognostic risk factors of CHF were identified by Cox regression analysis. The nomogram chart scoring model was constructed.
Results: The Cox multivariate regression analysis showed that traditional prognostic factors such as age (P=0.011), BMI (P=0.048), NYHA classification (P< 0.001), creatinine (P< 0.001), and systemic inflammatory markers including LMR (P=0.001), and PLR (P=0.015) were independent prognostic factors for CHF patients. Integrated with traditional and inflammatory prognostic factors, a nomogram was established, which yielded a C-index value of 0.739 (95% CI: 0.714– 0.764) in the derivation cohort and 0.713 (95% CI: 0.668– 0.758) in the validation cohort, respectively. The calibration curves exhibited good performance of the nomogram in predicting the adverse outcomes for patients with CHF. In subgroups (HFrEF, HFmrEF, and HFpEF groups), the systematic inflammatory markers-based nomograms proved to be effective prediction tools for patients’ adverse overcomes, as well.
Conclusion: The nomogram combining systemic inflammatory markers and traditional risk factors has satisfactory predictive performance for adverse outcomes (mortality and readmission) in patients with CHF.
Keywords: chronic heart failure, inflammation, prognosis, systemic inflammatory markers, nomogram